As top-selling Keytruda inches…
As top-selling Keytruda inches closer to its 2028 patent cliff, [...]
As the first CAR-T treatment for…
As the first CAR-T treatment for an autoimmune disease draws [...]
Pfizer has pumped the brakes on…
Pfizer has pumped the brakes on six early-stage assets, including [...]
Exxel Pharma is eyeing a listing…
Exxel Pharma is eyeing a listing on the NYSE American [...]
La ostarina, el fármaco que está en el centro del dopaje deportivo
El fármaco prometía profundos cambios en tratamientos médicos. Algo inesperado [...]
AstraZeneca will have to negotiate…
AstraZeneca will have to negotiate what appears to be a [...]
A U.K. marketing watchdog has…
A U.K. marketing watchdog has sanctioned Sanofi after ruling its [...]
The Key to Managing Tariffs: Be Big and Have the President’s Ear
Several large American manufacturers are thriving despite the threat of [...]
With Valentine’s Day coming up,…
With Valentine’s Day coming up, AbbVie has love on the [...]
The FDA issued complete response…
The FDA issued complete response letters to Aquestive Therapeutics and [...]